Roche
RO.SW
#38
Rank
NZ$588.43 B
Marketcap
NZ$739.60
Share price
1.37%
Change (1 day)
37.66%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: NZ$34.93

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$34.93. In 2025 the company made an earnings per share (EPS) of NZ$34.93 an increase over its 2024 EPS that were of NZ$19.66.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$34.9377.67%
2024NZ$19.66-32.84%
2023NZ$29.271.95%
2022NZ$28.71-6.29%
2021NZ$30.64-5.53%
2020NZ$32.4316.56%
2019NZ$27.8230.3%
2018NZ$21.3520.22%
2017NZ$17.76-5.81%
2016NZ$18.864.62%
2015NZ$18.02-5.13%
2014NZ$19.00-25.05%
2013NZ$25.3521.73%
2012NZ$20.823.82%
2011NZ$20.068.16%
2010NZ$18.5423.72%
2009NZ$14.99-12.31%
2008NZ$17.09-0.34%
2007NZ$17.1532.13%
2006NZ$12.9842.56%
2005NZ$9.10-22.7%
2004NZ$11.78132.85%
2003NZ$5.06-148.05%
2002NZ-$10.53-209.09%
2001NZ$9.65-57.03%
2000NZ$22.4653.29%
1999NZ$14.6531.24%
1998NZ$11.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.93-57.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.00-65.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.24-93.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.17-82.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.75-29.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.37-87.48%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$9.33-73.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.08-82.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.64-80.98%๐Ÿ‡ฌ๐Ÿ‡ง UK